Literature DB >> 3164085

Colony growth characteristics in chronic myelomonocytic leukemia.

K Geissler1, W Hinterberger, P Bettelheim, O Haas, K Lechner.   

Abstract

Using cell culture studies specific in-vitro characteristics have been reported for Philadelphia chromosome positive myelogenous leukemia (Ph+ CML) and for juvenile chronic myelogenous leukemia (JCML) previously. We performed cell culture studies in four patients with chronic myelomonocytic leukemia (CMML) and demonstrated the following in-vitro features: excessively increased circulating CFU-C, while BFU-E and CFU-mix were either moderately increased or not detectable; CFU-C colony formation from CMML mononuclear cells (MNC) without addition of exogenous colony stimulating activity (CSA), even after depletion from adherent cells; failing inhibition of CMML MNC on normal BFU-E colony formation. These in-vitro characteristics point to CMML as a distinct entity. In two CMML-patients investigated CFU-C proliferation appeared to some extent inhibited by the addition of IFN-alpha, IFN-gamma and TNF-alpha to cell cultures.

Entities:  

Mesh:

Year:  1988        PMID: 3164085     DOI: 10.1016/0145-2126(88)90055-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  17 in total

1.  Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?

Authors:  Klaus Geissler; Eva Jäger; Agnes Barna; Thamer Sliwa; Paul Knöbl; Ilse Schwarzinger; Heinz Gisslinger; Peter Valent
Journal:  Haematologica       Date:  2016-12       Impact factor: 9.941

2.  I walk the line: how to tell MDS from other bone marrow failure conditions.

Authors:  Lukasz P Gondek; Amy E DeZern
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 3.  Translational hematology.

Authors:  Klaus Geissler
Journal:  Wien Med Wochenschr       Date:  2014-09-10

4.  Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experience.

Authors:  Wolfgang Füreder; Andrea Paulitsch-Buckingham; Werner Rabitsch; Eva Jäger; Ilse Schwarzinger; Wolfgang R Sperr; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

5.  Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

Authors:  K Akashi; T Shibuya; M Harada; Y Takamatsu; N Uike; T Eto; Y Niho
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 6.  Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.

Authors:  Giacomo Coltro; Mrinal M Patnaik
Journal:  Curr Oncol Rep       Date:  2019-11-14       Impact factor: 5.075

7.  Prognostic factors in juvenile chronic granulocytic leukaemia.

Authors:  G Owen; I J Lewis; M Morgan; A Robinson; R F Stevens
Journal:  Br J Cancer Suppl       Date:  1992-08

Review 8.  Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.

Authors:  Leopold Ohler; Klaus Geissler; Wolfgang Hinterberger
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

Review 9.  Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).

Authors:  Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R Sperr; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

Review 10.  The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.

Authors:  Amy E DeZern; Mikkael A Sekeres
Journal:  Oncologist       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.